Menlo's serlopitant shows encouraging action in reducing itching in EB patients [Seeking Alpha]
MENLO THERAPEUTICS INC COMMON (MNLO)
Last menlo therapeutics inc common earnings: 3/3 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.menlotherapeutics.com/investor-relations
Company Research
Source: Seeking Alpha
Menlo's serlopitant shows encouraging action in reducing itching in EB patientsResults from an exploratory study evaluating the effect of Menlo Therapeutics' (MNLO+0.5%) serlopitant in epidermolysis bullosa (EB) patients experiencing chronic itching (pruritis) showed a treatment effect. The data were presented at the International Investigative Dermatology Conference in Washington, D.C.After eight weeks of treatment, patients receiving serlopitant experienced a 40% greater decrease in itch score from baseline compared to placebo (2.1 vs. 1.5). 43% of subjects achieved at least a three-point reduction compared to 14% for control.The company licensed Phase 3-stageserlopitant, a small molecule neurokinin 1 receptor (NK1-R) inhibitor, from Merck in 2012.Previously:Menlo Therapeutics on deck for IPO (Jan. 2)Click to subscribe to real-time analytics on MNLONow read:Menlo Crashes On Failed Phase 2 Atopic Dermatitis Study, A Great Buying Opportunity? »
Show less
Read more
Impact Snapshot
Event Time:
MNLO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNLO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNLO alerts
High impacting MENLO THERAPEUTICS INC COMMON news events
Weekly update
A roundup of the hottest topics